CN Patent

CN102056917B — 作为β3肾上腺素能受体激动剂的羟甲基吡咯烷

Assigned to Merck Sharp and Dohme LLC · Expires 2014-11-05 · 12y expired

What this patent protects

本发明提供式(I)的化合物、其药物组合物和使用其治疗或预防由β3肾上腺素能受体激活介导的疾病的方法。

USPTO Abstract

本发明提供式(I)的化合物、其药物组合物和使用其治疗或预防由β3肾上腺素能受体激活介导的疾病的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN102056917B
Jurisdiction
CN
Classification
—
Expires
2014-11-05
Drug substance claim
No
Drug product claim
No
Assignee
Merck Sharp and Dohme LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.